MEDNAX (NYSE: MD) reported earnings on July 30. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended June 30 (Q2), MEDNAX met expectations on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly. GAAP earnings per share grew.

Margins dropped across the board.

Revenue details
 MEDNAX booked revenue of $529.2 million. The 13 analysts polled by S&P Capital IQ anticipated net sales of $532.0 million on the same basis. GAAP reported sales were 18% higher than the prior-year quarter's $449.5 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $1.37. The 15 earnings estimates compiled by S&P Capital IQ predicted $1.36 per share. GAAP EPS of $1.37 for Q2 were 12% higher than the prior-year quarter's $1.22 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 33.6%, 100 basis points worse than the prior-year quarter. Operating margin was 21.4%, 80 basis points worse than the prior-year quarter. Net margin was 13.1%, 40 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $562.2 million. On the bottom line, the average EPS estimate is $1.49.

Next year's average estimate for revenue is $2.16 billion. The average EPS estimate is $5.45.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 172 members out of 179 rating the stock outperform, and seven members rating it underperform. Among 61 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 59 give MEDNAX a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on MEDNAX is outperform, with an average price target of $98.50.

Is MEDNAX the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.